Proposals Sought for Use of PLCO Data and Biospecimens || NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute

Proposals Sought for Use of PLCO Data and Biospecimens
Data and biospecimens from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial are available to qualified researchers through a peer-review process. The Etiology and Early Marker Studies (EEMS) program accepts proposals for access to PLCO biospecimens twice a year, with the current cycle ending on January 16, 2012, at 5:00 p.m. ET.

By collecting biologic materials and risk factor information from trial participants before the diagnosis of disease, EEMS—a component of the PLCO—provides a resource for cancer researchers who are studying cancer etiology and early detection. Etiologic studies investigate the environmental, biochemical, and genetic risk factors for cancer. Early detection studies aim to develop reproducible, reliable biomarkers of early disease.

Proposals will be accepted for the next EEMS review cycle starting December 1. Details of the review process and application materials are available online. Questions may be directed to parplcohelpdesk@westat.com or 240-314-2313. Proposals for the next cycle will be accepted in June or July 2012.

NCI Cancer Bulletin for November 29, 2011 - National Cancer Institute